Agilent Technologies (A) Cash from Investing Activities (2009 - 2026)
Agilent Technologies (A) posted quarterly Cash from Investing Activities of -$77.0 million for Q2 2026, up 32.46% year-over-year from -$58.1 million in Q2 2025, and up 17.2% quarter-over-quarter from -$93.0 million in Q1 2026.
Agilent Technologies (A) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Agilent Technologies (A) has reported Cash from Investing Activities for 18 consecutive years, with -$77.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash from Investing Activities rose 32.46% year-over-year to -$77.0 million; the TTM figure through Apr 2026 stood at -$356.0 million (up 71.79% YoY), while the FY2025 annual figure was -$394.0 million, up 68.68% from the prior year.
- Cash from Investing Activities advanced to -$77.0 million in Q2 2026 per A's latest filing, from -$93.0 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$40.0 million in Q4 2023 and bottomed at -$954.0 million in Q4 2024.
- Historically, Cash from Investing Activities has averaged -$137.2 million across 5 years, with a median of -$93.5 million in 2025.
- Annual changes were most pronounced in 2024 — Cash from Investing Activities plunged 2285.0% — and 2025, when it jumped 90.57%.
- Agilent Technologies' Cash from Investing Activities stood at -$110.0 million in 2022, then jumped by 63.64% to -$40.0 million in 2023, then slumped by 2285.0% to -$954.0 million in 2024, then surged by 90.57% to -$90.0 million in 2025, then climbed by 14.44% to -$77.0 million in 2026.
- Business Quant data shows A's Cash from Investing Activities at -$77.0 million in Q2 2026, -$93.0 million in Q1 2026, and -$90.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 209.29 Bn | 205.35 Bn | 8.34 Bn | 164.00 Mn |
| 2 | Danaher | 137.39 Bn | 133.06 Bn | 3.61 Bn | -10.15 Bn |
| 3 | Idexx Laboratories | 46.84 Bn | 46.64 Bn | 779.09 Mn | -25.50 Mn |
| 4 | Agilent Technologies | 39.29 Bn | 37.48 Bn | 990.00 Mn | -77.00 Mn |
| 5 | Natera | 39.28 Bn | 38.18 Bn | 696.04 Mn | -32.14 Mn |
| 6 | Iqvia Holdings | 37.90 Bn | 35.95 Bn | 1.44 Bn | -381.00 Mn |
| 7 | Illumina | 30.65 Bn | 29.49 Bn | 770.00 Mn | -122.00 Mn |
| 8 | Mettler Toledo International | 28.92 Bn | 28.87 Bn | 650.22 Mn | -1.94 Mn |
| 9 | Quest Diagnostics | 25.96 Bn | 25.64 Bn | 1.03 Bn | -134.00 Mn |
| 10 | Labcorp Holdings | 25.71 Bn | 24.73 Bn | 1.01 Bn | -322.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -77.00 Mn |
| Apr 30, 2026 | -77.00 Mn |
| Jan 31, 2026 | -93.00 Mn |
| Jan 31, 2026 | -93.00 Mn |
| Oct 31, 2025 | -90.00 Mn |
| Oct 31, 2025 | -90.00 Mn |
| Jul 31, 2025 | -96.00 Mn |
| Jul 31, 2025 | -96.00 Mn |
| Apr 30, 2025 | -114.00 Mn |
| Apr 30, 2025 | -114.00 Mn |
| Jan 31, 2025 | -94.00 Mn |
| Jan 31, 2025 | -94.00 Mn |
| Oct 31, 2024 | -954.00 Mn |
| Oct 31, 2024 | -954.00 Mn |
| Jul 31, 2024 | -100.00 Mn |
| Jul 31, 2024 | -100.00 Mn |
| Apr 30, 2024 | -109.00 Mn |
| Apr 30, 2024 | -109.00 Mn |
| Jan 31, 2024 | -95.00 Mn |
| Jan 31, 2024 | -95.00 Mn |